UID:
almahu_9949772760802882
Umfang:
XVI, 309 p. 25 illus., 24 illus. in color.
,
online resource.
Ausgabe:
1st ed. 2024.
ISBN:
9789819730018
Inhalt:
The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.
Anmerkung:
1. An Overview of Biosimilars -- 2. Immunobiology of Cancer -- 3. Mechanism of Biosimilars for the treatment of Cancer -- 4. Biosimilars in Colorectal Cancer -- 5. Biosimilars in Cervical Caner -- 6. Biosimilars in Prostate Cancer -- 7. Biosimilars in Gastric Cancer -- 8. Biosimilars in Lung Cancer -- 9. A Recent Overview of The Growing Applications of Biosimilars in Pancreatic Cancer Management- Current Picture and Future Perspectives -- 10. Biosimilars in Breast Cancer -- 11. Biosimilars in Hepatocellular Carcinoma -- 12. Biosimilars in Ovarian Cancer -- 13. Biosimilars in Blood Cancer -- 14. Biosimilars in Clinical Trials -- 15. Regulatory Considerations of Biosimilars in Cancer -- 16. Future Scope of Biosimilars for the Treatment of Various Cancers.
In:
Springer Nature eBook
Weitere Ausg.:
Printed edition: ISBN 9789819730001
Weitere Ausg.:
Printed edition: ISBN 9789819730025
Weitere Ausg.:
Printed edition: ISBN 9789819730032
Sprache:
Englisch
DOI:
10.1007/978-981-97-3001-8
URL:
https://doi.org/10.1007/978-981-97-3001-8
URL:
Volltext
(URL des Erstveröffentlichers)
